SOPHARMA AD - Current report 35 buy back 25042012 (35/2012)

| | POLISH FINANCIAL SUPERVISION AUTHORITY | | | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| | | | | UNI - EN REPORT No | 35 | / | 2012 | | | | |
| | Date of issue: | 2012-04-25 | | | | | | | | | |
| | Short name of the issuer | | | | | | | | | | |
| | SOPHARMA AD | | | | | | | | | | |
| | Subject | | | | | | | | | | |
| | Current report 35 buy back 25042012 | | | | | | | | | | |
| | Official market - legal basis | | | | | | | | | | |
| | Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | | | | | | | | | | |
| | Unofficial market - legal basis | | | | | | | | | | |
| | Contents of the report: | | | | | | | | | | |
| | ACQUISITION OF OWN SHARES Current report No. 35 /2012 Dated 25 April 2012 The Board of Directors of SOPHARMA AD (the ?Company") hereby informs that from 19 April 2012 up to and including 24 April 2012 the Company bought 200 own shares representing 0.00015% of the share capital of the Company, to the total value of 521 BGN on the Bulgarian Stock Exchange. The average price per share was 2.61 BGN. The shares have been bought on the basis of the general meeting resolution of 23.06.2010. The intention of the Company is to use the repurchased shares in the future for the purpose of providing them to shareholders of companies targeted in mergers. The total number of own shares after these transactions is 3073166, representing 2.328% of the share capital of the Company. Legal grounds: Art. 56.1 of the Act on Public Offering, Conditions Governing the Introduction of Financial Instruments to Organized Trading, and Public Companies dated 29 July 2005. Signatures of individuals authorized to represent the Company
Ognian Donev | | | | | | | | | | |
| | Annexes | | | | | | | | | | |
| | File | Description | | | | | | | | | |
| | Current report 35 buy back 25042012.doc | Current report 35 buy back 25042012 | | | | | | | | | |

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

| | | SOPHARMA AD | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | (fullname of the issuer) | | | | | |
| | | SOPHARMA AD | | Farmaceutyczny (far) | | | |
| | | (short name of the issuer) | | (sector according to clasification of the WSE in Warsow) | | | |
| | | 1220 | | Sofia | | | |
| | | (post code) | | (city) | | | |
| | | IlienskoShosse | | 16 | | | |
| | | (street) | | (number) | | | |
| | | +359 2 813 42 00 | | +359 2 936 02 86 | | | |
| | | (phone number) | | | (fax) | | |
| | | (e-mail) | | | (web site) | | |
| | | nd | | | | | |
| | | (NIP)
| | | (REGON) | | |

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY